Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-18 08:50:34 UTC |
---|
Update Date | 2022-03-07 02:49:11 UTC |
---|
HMDB ID | HMDB0001932 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Metoprolol |
---|
Description | Metoprolol is a selective beta1 receptor blocker used in treatment of several diseases of the cardiovascular system. It is marketed under the brand name Lopressor by Novartis, and Toprol (in the USA); Seleken or Selokeen (elsewhere); A selective adrenergic beta-1-blocking agent with no stimulatory action. It's binding to plasma albumin is weaker than alprenolol and it may be useful in the treatment of several diseases of the cardiovascular system; Metoprolol is a selective beta1 receptor blocker used in treatment of several diseases of the cardiovascular system. It is marketed under the brand name Lopressor by Novartis, and Toprol (in the USA); Seleken or Selokeen (elsewhere); as Minax by Alphapharm (in Australia), as Betaloc by AstraZeneca and as Corvitol by Berlin-Chemie AG; A selective adrenergic beta-1-blocking agent with no stimulatory action. It's binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias; as Minax by Alphapharm (in Australia), as Betaloc by AstraZeneca and as Corvitol by Berlin-Chemie AG. |
---|
Structure | COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 |
---|
Synonyms | Value | Source |
---|
(RS)-Metoprolol | ChEBI | 1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | ChEBI | (+/-)-metoprolol | HMDB | Beatrolol | HMDB | DL-Metoprolol | HMDB | Lopresor | HMDB | Lopresoretic | HMDB | Lopressor | HMDB, MeSH | Meijoprolol | HMDB | Metohexal | HMDB | Metoprolol succinate | HMDB, MeSH | Metoprolol tartrate | HMDB, MeSH | Metoprololum | HMDB | Preblok | HMDB | Presolol | HMDB | Seloken | HMDB, MeSH | Seroken | HMDB | Spesicor | HMDB, MeSH | Toprol-XL | HMDB, MeSH | Beloc duriles | MeSH, HMDB | Beloc-duriles | MeSH, HMDB | Betaloc | MeSH, HMDB | Succinate, metoprolol | MeSH, HMDB | Toprol | MeSH, HMDB | BelocDuriles | MeSH, HMDB | Betaloc astra | MeSH, HMDB | CR-XL, Metoprolol | MeSH, HMDB | Spesikor | MeSH, HMDB | Tartrate, metoprolol | MeSH, HMDB | Toprol XL | MeSH, HMDB | Metoprolol CR-XL | MeSH, HMDB | Betaloc-astra | MeSH, HMDB | Betalok | MeSH, HMDB | Metoprolol CR XL | MeSH, HMDB | ToprolXL | MeSH, HMDB | BetalocAstra | MeSH, HMDB |
|
---|
Chemical Formula | C15H25NO3 |
---|
Average Molecular Weight | 267.3639 |
---|
Monoisotopic Molecular Weight | 267.183443671 |
---|
IUPAC Name | 1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol |
---|
Traditional Name | metoprolol |
---|
CAS Registry Number | 37350-58-6 |
---|
SMILES | COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 |
---|
InChI Identifier | InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 |
---|
InChI Key | IUBSYMUCCVWXPE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tyrosols and derivatives. Tyrosols and derivatives are compounds containing a hydroxyethyl group attached to the C4 carbon of a phenol group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenols |
---|
Sub Class | Tyrosols and derivatives |
---|
Direct Parent | Tyrosols and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tyrosol derivative
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Monocyclic benzene moiety
- 1,2-aminoalcohol
- Secondary alcohol
- Dialkyl ether
- Secondary amine
- Secondary aliphatic amine
- Ether
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Alcohol
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 1.88 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Metoprolol,1TMS,isomer #1 | COCCC1=CC=C(OCC(CNC(C)C)O[Si](C)(C)C)C=C1 | 2063.1 | Semi standard non polar | 33892256 | Metoprolol,1TMS,isomer #2 | COCCC1=CC=C(OCC(O)CN(C(C)C)[Si](C)(C)C)C=C1 | 2204.3 | Semi standard non polar | 33892256 | Metoprolol,2TMS,isomer #1 | COCCC1=CC=C(OCC(CN(C(C)C)[Si](C)(C)C)O[Si](C)(C)C)C=C1 | 2253.9 | Semi standard non polar | 33892256 | Metoprolol,2TMS,isomer #1 | COCCC1=CC=C(OCC(CN(C(C)C)[Si](C)(C)C)O[Si](C)(C)C)C=C1 | 2252.4 | Standard non polar | 33892256 | Metoprolol,2TMS,isomer #1 | COCCC1=CC=C(OCC(CN(C(C)C)[Si](C)(C)C)O[Si](C)(C)C)C=C1 | 2473.2 | Standard polar | 33892256 | Metoprolol,1TBDMS,isomer #1 | COCCC1=CC=C(OCC(CNC(C)C)O[Si](C)(C)C(C)(C)C)C=C1 | 2293.9 | Semi standard non polar | 33892256 | Metoprolol,1TBDMS,isomer #2 | COCCC1=CC=C(OCC(O)CN(C(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 2457.9 | Semi standard non polar | 33892256 | Metoprolol,2TBDMS,isomer #1 | COCCC1=CC=C(OCC(CN(C(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C=C1 | 2709.8 | Semi standard non polar | 33892256 | Metoprolol,2TBDMS,isomer #1 | COCCC1=CC=C(OCC(CN(C(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C=C1 | 2642.0 | Standard non polar | 33892256 | Metoprolol,2TBDMS,isomer #1 | COCCC1=CC=C(OCC(CN(C(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C=C1 | 2685.3 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-7920000000-15359015d85b4c565e86 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9122000000-12f9e089d37951143a41 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metoprolol GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol Quattro_QQQ 10V, N/A-QTOF (Annotated) | splash10-0v0c-3248359000-0353ef81c3bc6d7fcfd5 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol Quattro_QQQ 25V, N/A-QTOF (Annotated) | splash10-014l-2514911000-b5f7785723f1eaf61e6f | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol Quattro_QQQ 40V, N/A-QTOF (Annotated) | splash10-05ir-1729351100-fb362124379cb4616c5e | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-QTOF , positive-QTOF | splash10-01b9-9760000000-90ea4861dda115391e26 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-014l-0920000000-b7c75fc96ea4b12a1f40 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-014i-0090000000-5e678ec3b5c3302abb3c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-014i-0190000000-0ea5b7fc1dda907b176b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-01b9-4940000000-5e4d95fb248589c9af91 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-05gi-4900000000-73204756032f7604c22e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-05fr-4900000000-597c5d64a09cf1b8f88d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-0zml-5900000000-ca840796f27bfcb3bd0f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-014i-0090000000-9ae9e49826b05fa823f5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-014i-0190000000-cfdea758641b8b5c956e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-01b9-3940000000-248e03350c5dfe8e1302 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-05gi-4900000000-24d3886dc7605253aeb8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-05gi-4900000000-08c6d3455af24f523db2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-0zmi-5900000000-9b22afca158afbaeb6d1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-ITFT , positive-QTOF | splash10-014l-0920000000-851dcbef33e79ed22643 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metoprolol LC-ESI-QTOF , positive-QTOF | splash10-014i-0090000000-61bef9702ed80c36d107 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metoprolol 10V, Positive-QTOF | splash10-014i-1290000000-e429d824fc6518e2de0f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metoprolol 20V, Positive-QTOF | splash10-00xr-9870000000-6859dfe077cd63365e3b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metoprolol 40V, Positive-QTOF | splash10-00di-9500000000-84deaf041eadbd4d3ea2 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metoprolol 10V, Negative-QTOF | splash10-0gb9-1790000000-1fa6e9e32d3d6f058f89 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metoprolol 20V, Negative-QTOF | splash10-0udi-1900000000-0545f16ae4bdd137d91e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metoprolol 40V, Negative-QTOF | splash10-0ldr-3900000000-cfffc2daf6eda94b4e60 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Membrane (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.071 +/- 0.0076 uM | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4027 |
---|
KEGG Compound ID | C07202 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Metoprolol |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 4171 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 6904 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Palmer, Sven; Sidenqvist, Michael. Process for the preparation of metoprolol. PCT Int. Appl. (1998), 12 pp. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Bauer LA, Horn JR, Maxon MS, Easterling TR, Shen DD, Strandness DE Jr: Effect of metoprolol and verapamil administered separately and concurrently after single doses on liver blood flow and drug disposition. J Clin Pharmacol. 2000 May;40(5):533-43. [PubMed:10806607 ]
- Murthy SS, Shetty HU, Nelson WL, Jackson PR, Lennard MS: Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol. Biochem Pharmacol. 1990 Oct 1;40(7):1637-44. [PubMed:2222517 ]
- Chaturvedi AK, Smith DR, Canfield DV: A fatality caused by accidental production of hydrogen sulfide. Forensic Sci Int. 2001 Dec 1;123(2-3):211-4. [PubMed:11728749 ]
|
---|